@hellmutaugustin.bsky.social & team @uniheidelberg.bsky.social find ectodomain cleavage of the vascular receptor Tie1 distinguishes the inflammatory from the angiogenic functions of Angiopoietin-Tie signaling, uncoupling two fundamental vascular programs: doi.org/10.1172/JCI2...
Noncanonical mTORC1-TFEB activation promotes hepatocyte plasticity and high-grade malignancy in hepatocellular carcinoma: doi.org/10.1172/JCI2...
TSC1/2 mutations define an aggressive subtype of liver cancer.
Here, Zhang et al. find loss of hepatic TSC1 leads to noncanonical TFEB activation and promotes hepatocyte plasticity & tumor heterogeneity associated with high-grade malignancy in mouse and human HCC: doi.org/10.1172/JCI2...
Sunday Readđź’«: What can 3,839,400 sibling pairs tell us about autoimmune disease? Eriksson et al. @ki.se quantified genetic correlations across 22 autoimmune diseases, showing substantial cluster-specific genetic overlap that largely aligns
with affected tissue types: doi.org/10.1172/JCI2...
Weekend Spotlight💫: As part of JCI’s review series on emerging therapeutic strategies in breast cancer, Fanucci et al. present: Toward targeted therapeutics for lobular breast cancer: doi.org/10.1172/JCI2...
stoverlab.bsky.social
A vasopressin gate transforms social distress into caregiving: doi.org/10.1172/JCI2...
Jonathan P. Fadok comments on Geng et al.: doi.org/10.1172/JCI2...
Hypothalamic-amygdala-VTA circuit reinforces caregiving-like behavior doi.org/10.1172/JCI2...
Geng et al. show that vasopressin secretion initiates a positive feedback loop to promote grooming of an injured mouse, transforming distress into a prosocial response.
Behind the Paper: Wen Luo (corresponding author, rt) & Huijuan Wang (1st author, lft) capture images of embryonic hearts (1/2); and Huijuan Wang (1st author, lft) & Haosheng Zhang (co‑1st author, rt) isolate mouse embryonic heart tissues (2/2) iat the Institute of Modern Biology, Nanjing University
HAND2 lends a hand in coronary artery formation: doi.org/10.1172/JCI2...
Wang et al. identify HAND2 as a key cardiac transcription factor that helps build coronary arteries, revealing potential therapeutic targets for congenital and ischemic heart disease.
As part of JCI’s review series on emerging therapeutic strategies in breast cancer, Kay et al. @petermaccc.bsky.social present: Breast cancer immunogenicity as a spectrum: evolving concepts and therapeutic implications: doi.org/10.1172/JCI2...
c-KIT expands the tool kit for treating arteriovenous malformation: doi.org/10.1172/JCI2...
Ruilin Wu & Jason E. Fish provide a Commentary on companion articles, Gahn et al. (doi.org/10.1172/JCI1...) and and Drapé et al. (doi.org/10.1172/JCI1...).
#AVM #HHT #VascularBiology
We’re excited to revisit the 2021 Albert Lasker Basic Medical Research Award: doi.org/10.1172/JCI1...
“My plan was to purify the rhodopsin from this Chlamydomonas creature, and I thought I could do it in a year. But it took me 15 years, actually.”—Peter Hegemann
🏅 Congratulations to Karl Deisseroth, Peter Hegemann, and Georg Nagel for the #NobelPrize in Physiology or Medicine 2026 on optogenetics!
See the Commentary by Ruilin Wu & Jason E. Fish @FishLab_UHN, highlighting Gahn et al. and companion article, Drapé et al.: doi.org/10.1172/JCI2...
Unleashing c-KIT activates maladaptive vascular remodeling in HHT doi.org/10.1172/JCI1...
Gahn et al. show that SMAD4 limits c-KIT expression in endothelial cells. In a SMAD4-deficient HHT model, c-KIT derepression dysregulated mechanosensory-driven vascular remodeling.
See the Commentary by Ruilin Wu & Jason E. Fish, highlighting Drapé et al. and the companion article Gahn et al.: doi.org/10.1172/JCI2...
Abnormal role of c-KIT in vascular endothelium drives brain AVMs
doi.org/10.1172/JCI1...
Drapé et al. show that pro-angiogenic c-KIT+ endothelial states induce brain arteriovenous malformations in an ALK1-deficient model of hereditary hemorrhagic telangiectasia.
Viewpoint: Small populations, big impact: Leveraging rare disease gene therapies to benefit millions: doi.org/10.1172/JCI2...
Stephanie Cherqui discusses discoveries in rare disease research that have changed therapeutic principles for other diseases.
As part of JCI’s review series on emerging therapeutic strategies in breast cancer, Chenxu Guo & Leif W. Ellisen present: Antibody-drug conjugates in #BreastCancer: redefining targeted therapy: doi.org/10.1172/JCI2...
Why a positive rheumatoid factor test does not always mean rheumatoid arthritis: doi.org/10.1172/JCI2...
Luc Van Kaer comments on Hocaoglu and Sawalha: doi.org/10.1172/JCI2...
